ask="4.49"
ask_size="400"
average_daily_volume="301825"
bid="3.90"
bid_size="400"
book_value="3.30"
change="-0.13"
change_from_200_day_moving_average="1.18"
change_from_50_day_moving_average="-0.00"
change_from_52_week_high="-6.82"
change_From_52_week_low="0.67"
change_in_percent="-3.03%"
close="4.16"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.13"
ebitda="-44.46M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.53"
ex_dividend_date="N/A"
float_shares="13906000"
high="4.29"
high_52_weeks="10.98"
last_trade_date="3/14/2017"
last_trade_price="4.16"
last_trade_size="1000"
last_trade_time="4:00pm"
low="4.03"
low_52_weeks="3.49"
market_capitalization="93.86M"
moving_average_200_day="2.98"
moving_average_50_day="4.16"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.26"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+39.56%"
percent_change_from_50_day_moving_average="-0.03%"
percent_change_from_52_week_high="-62.11%"
percent_change_from_52_week_low="+19.20%"
previous_close="4.29"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.30"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22562000"
short_ratio="2.05"
stock_exchange="NMS"
symbol="CASC"
volume="105366"
weeks_range_52="3.49 - 10.98"
